Analytical Data
-
Gene name
TNFRSF19
- Application
-
Alternative Names
TNFRSF19；TAJ；TROY；Tumor necrosis factor receptor superfamily member 19
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NS68-2
-
Expression Region
1-170aa
-
AA Sequence
MALKVLLEQE KTFFTLLVLL GYLSCKVTCE SGDCRQQEFR DRSGNCVPCN QCGPGMELSK ECGFGYGEDA QCVTCRLHRF KEDWGFQKCK PCLDCAVVNR FQKANCSATS DAICGDCLPG FYRKTKLVGF QDMECVPCGD PPPPYEPHCA SKVNLVKIAS TASSPRDTAL
-
Molecular Weight
17 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TNFRSF19, also known as human tumor necrosis factor receptor superfamily member 19, is a key protein involved in various cellular processes, including immune response regulation and cellular signaling pathways. Its role has garnered significant interest in both basic and clinical research due to its implications in cancer biology and autoimmune diseases. Given that TNFRSF19 is implicated in the modulation of inflammatory responses and T cell activation, understanding its molecular mechanisms can provide insight into therapeutic targets for conditions such as multiple sclerosis and rheumatoid arthritis. The study of recombinant TNFRSF19 proteins allows for the exploration of its structure, function, and interactions with other cellular components. These recombinant proteins serve as essential tools for elucidating the signaling pathways mediated by TNFRSF19 and for evaluating their potential as therapeutic agents in diseases characterized by dysregulated immune responses. By employing techniques such as protein expression, purification, and functional assays, researchers aim to dissect the complex biology of TNFRSF19, thus paving the way for novel intervention strategies that could exploit its regulatory functions in immunity and inflammation.
